Literature DB >> 10024675

p16 involvement in primary bladder tumors: analysis of deletions and mutations.

E Baud1, P Catilina, Y J Bignon.   

Abstract

Different studies have proposed that genetic alterations leading to inactivation of a tumor suppressor gene on chromosome 9 is an important early event in bladder tumorigenesis. Recent reports have described the p16 gene as the main target. In order to better define its role, we studied 9p21 deletions by microsatellite analysis and its coding sequence. Forty-eight percent of the 44 samples we studied showed LOH surrounding p16. Three of these 44 samples displayed point mutations in p16 and three others were suspected of homozygous deletion. These results suggest that simultaneous loss of both p16 alleles, by point mutation or homozygous deletion, seems to be infrequent in bladder tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024675     DOI: 10.3892/ijo.14.3.441

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.

Authors:  Lan Mo; Xiaoyong Zheng; Hong-Ying Huang; Ellen Shapiro; Herbert Lepor; Carlos Cordon-Cardo; Tung-Tien Sun; Xue-Ru Wu
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

2.  Two target regions of allelic loss on chromosome 9 in urinary-bladder cancer.

Authors:  K Ohgaki; K Minobe; K Kurose; A Iida; T Habuchi; O Ogawa; Y Kubota; M Akimoto; M Emi
Journal:  Jpn J Cancer Res       Date:  1999-09

3.  Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms.

Authors:  Louis S Pymar; Fiona M Platt; Jon M Askham; Ewan E Morrison; Margaret A Knowles
Journal:  Hum Mol Genet       Date:  2008-04-07       Impact factor: 6.150

Review 4.  Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications.

Authors:  Martina Minoli; Mirjam Kiener; George N Thalmann; Marianna Kruithof-de Julio; Roland Seiler
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.